The global bioprocess bags market size accounted for USD 4.42 billion in 2024, grew to USD 5.21 billion in 2025, and is expected to be worth around USD 23.15 billion by 2034, registering a healthy CAGR of 18.01% between 2024 and 2034. The North America bioprocess bags market size is predicted to increase from USD 1.59 billion in 2024 and is estimated to grow at the fastest CAGR of 18.17% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Bioprocess Bags Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Bioprocess Bags Market Revenue and Volume, by Product Type, 2024-2034
8.1.1 Single-use bioprocessing bags
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Multi-use bioprocessing bags
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1. Bioprocess Bags Market Revenue and Volume, by Application, 2024-2034
9.1.1. Upstream process
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Downstream process
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1.3. Process development
9.1.3.1. Market Revenue and Volume Forecast (2021-2034)
9.1.4. Media preparation
9.1.4.1. Market Revenue and Volume Forecast (2021-2034)
10.1. Bioprocess Bags Market Revenue and Volume, by End-User, 2024-2034
10.1.1. Pharmaceutical companies
10.1.1.1. Market Revenue and Volume Forecast (2021-2034)
10.1.2. Biopharmaceutical companies
10.1.2.1. Market Revenue and Volume Forecast (2021-2034)
10.1.3. Biotechnology labs
10.1.3.1. Market Revenue and Volume Forecast (2021-2034)
10.1.4. Academic labs
10.1.4.1. Market Revenue and Volume Forecast (2021-2034)
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.1.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.1.3. Market Revenue and Volume Forecast, by End-User (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.1.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.1.4.3. Market Revenue and Volume Forecast, by End-User (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.1.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.1.5.3. Market Revenue and Volume Forecast, by End-User (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.2.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.3. Market Revenue and Volume Forecast, by End-User (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.2.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.4.3. Market Revenue and Volume Forecast, by End-User (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.2.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.5.3. Market Revenue and Volume Forecast, by End-User (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.2.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.6.3. Market Revenue and Volume Forecast, by End-User (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.2.7.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.7.3. Market Revenue and Volume Forecast, by End-User (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.3.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.3. Market Revenue and Volume Forecast, by End-User (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.3.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.4.3. Market Revenue and Volume Forecast, by End-User (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.3.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.5.3. Market Revenue and Volume Forecast, by End-User (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.3.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.6.3. Market Revenue and Volume Forecast, by End-User (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.3.7.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.7.3. Market Revenue and Volume Forecast, by End-User (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.3. Market Revenue and Volume Forecast, by End-User (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.4.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.4.3. Market Revenue and Volume Forecast, by End-User (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.4.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.5.3. Market Revenue and Volume Forecast, by End-User (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.4.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.6.3. Market Revenue and Volume Forecast, by End-User (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.4.7.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.7.3. Market Revenue and Volume Forecast, by End-User (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.5.3. Market Revenue and Volume Forecast, by End-User (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.5.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.5.4.3. Market Revenue and Volume Forecast, by End-User (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.5.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.5.5.3. Market Revenue and Volume Forecast, by End-User (2021-2034)
12.1. Meissner Filtration Products, Inc
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Merck KgaA
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Thermo Fisher Scientific
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. ESI Technologies
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Biopure Technology Ltd.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Optimum Processing Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Flexbiosys Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Avintos AG.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Octane Biotech Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Novasep Holding SAS
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample